Biogen Inc. - Company & Market Research Reports

Home /
Companies /
Biogen Inc.

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 154
Genomics 73
Biopharmaceuticals 73
Immune Disorders Drugs 71
Biotechnology 50
Pharmaceuticals 42
Oncology Drugs 41
Musculoskeletal Disorders Drugs 41
Drug Discovery 37
Hematological Drugs 36
Biosimilars and Biosuperiors 31
Alzheimer's Disease Drugs 26
Infusions and Injectables 25
Cardiovascular Drugs 24
Allergy and Immunology 22
Clinical Trials 22
Optical Disorders Drugs 21
Mental Disorders Drugs 19
Neurology 17
Needles and Syringes 17
E-Healthcare 14
Respiratory Drugs 14
Psoriasis Drugs 14
Infectious Diseases Drugs 12
Optical 12
Immunosuppressive Drugs 12
Healthcare Services 11
Hematology 11
Gastrointestinal Drugs 11
Pharmaceutical Manufacturing 11
Drug Delivery 10
Drugs by Therapeutic Area 9
Lymphoma Drugs 9
Analgesics 9
Diagnostics 9
Endocrine and Metabolic Disorders Drugs 9
Therapeutic Area 8
Leukemia Drugs 8
Pulmonary Medicine 7
Liver and Kidney Disorders Drugs 7
Enzymes 5
Medical Devices 5
Oncology 5
Schizophrenia Drugs 5
Company Reports 4
Proteomics 4
Mental Health 4
Neurology Devices 4
Cardiology 4
Pharmaceutical Intermediates 3
Generic Drugs 3
Stem Cells 3
Hospital Management 3
Dermatology 3
Vitamins and Dietary Supplements 3
Gastroenterology 3
Dermatological Drugs 3
Urology and Nephrology 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
In Vitro Diagnostics 2
Managed Care 2
Diabetes Devices 2
Biomaterials 2
Biomarkers 2
Vaccines 2
Skin Cancer Drugs 2
Laboratory Equipment 2
Pediatrics 2
Anxiety Drugs 2
Addiction Disorders Drugs 1
Diabetes Drugs 1
Women's Health 1
Fertility Services 1
Lung Cancer Drugs 1
Colon Cancer Drugs 1
Cervical Cancer Drugs 1
Brain Cancer Drugs 1
Medical Imaging 1
Infectious Disease Testing 1
Transdermal and Transmucosal Drug Delivery 1
Contrast Media 1
Kidney Cancer Drugs 1
Nanomedicine 1
Antibiotics 1
Clinical Skills 1
Anatomy 1
Endocrinology 1
Allergy Drugs 1
Asthma Drugs 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

855 Results (Page 21 of 43)
- Relevance
  Sort by

Gene Therapy Market Industry Trends and Global Forecasts to 2035: By Therapeutic Area, Type of Vector, Type of Therapy, Type of Gene Delivery Method, Route of Administration, Geographical Region, Leading Market Players and Sales Forecast

 Report
June 2025
972 Pages
Global

From

€4241EUR$4,799USD£3,713GBP

Hematological Disorders Diagnostic And Therapeutic Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
February 2022
95 Pages
Global

From

€3200EUR$3,879USD£2,900GBP

Stem Cell Therapy Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3968EUR$4,490USD£3,474GBP

Antidepressants Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3968EUR$4,490USD£3,474GBP

Post-Traumatic Stress Disorder Therapeutics Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3968EUR$4,490USD£3,474GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

US Biosimilar industry outlook to 2028

 Report
October 2023
85 Pages
United States

From

€4286EUR$4,850USD£3,752GBP

Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market Industry Trends and Global Forecasts to 2035, by Scale of Operation, Type of Vector, Application Area, Therapeutic Area, Type of Manufacturer and Geographical Region

 Report
January 2025
768 Pages
Global

From

€4241EUR$4,799USD£3,713GBP

Gastrointestinal Therapeutics - Global Strategic Business Report

 Report
December 2025
193 Pages
Global

From

€5170EUR$5,850USD£4,526GBP

Global Genome Editing Market, 2023-2035: Focus on Technology, Industry Trends and Forecasts

 Report
January 2024
270 Pages
Global

From

€4241EUR$4,799USD£3,713GBP

Rare Hemophilia Factors Market Size, Share & Trends Analysis Report by Factor Deficiency Type, Drug Class (Recombinant Therapies, Prophylactic Treatments), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), and Region with Growth Forecasts, 2025-2030

 Report
February 2025
100 Pages
Global

From

€5258EUR$5,950USD£4,603GBP

Central Nervous System Collaboration and Licensing Deals 2019-2025

 Report
October 2025
500 Pages
Global

From

€3530EUR$3,995USD£3,091GBP

Cancer Immunotherapy Market 2025-2029 - Forecasts for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer, with Executive and Consultant Guides

 Report
December 2025
262 Pages
Global

From

€6181EUR$6,995USD£5,412GBP

Protein Engineering Global Market Report 2025

 Report
January 2025
250 Pages
Global

From

€3968EUR$4,490USD£3,474GBP

Major Depressive Disorder Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3968EUR$4,490USD£3,474GBP

Postpartum Depression Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3968EUR$4,490USD£3,474GBP

Postpartum Depression - Market Insights, Epidemiology, and Market Forecast - 2034

 Report
April 2025
200 Pages
Global

From

€5620EUR$6,360USD£4,920GBP

€7025EUR$7,950USD£6,151GBP

Gene Therapy R&D Market Report 2024-2034

 Report
May 2024
340 Pages
Global

From

€5143EUR$6,023USD£4,350GBP

Protein Therapeutics - Global Strategic Business Report

 Report
December 2025
181 Pages
Global

From

€5170EUR$5,850USD£4,526GBP

Biological Drugs - Global Strategic Business Report

 Report
December 2025
196 Pages
Global

From

€5170EUR$5,850USD£4,526GBP

Antibody Therapeutics Market - Global Strategic Business Report

 Report
December 2025
577 Pages
Global

From

€5170EUR$5,850USD£4,526GBP

855 Results (Page 21 of 43)
- 1
- 19
- 20
- 21
- 22
- 23

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.